News & Updates

Pravastatin exposure during pregnancy carries no adverse neurodevelopmental risk for offspring

11 Mar 2023

Children born to mothers who were taking pravastatin during the second and third trimesters of pregnancy do not appear to have any identifiable long-term neurodevelopmental safety risks, as reported in a study.

Pravastatin exposure during pregnancy carries no adverse neurodevelopmental risk for offspring

11 Mar 2023

Prenatal exposure to plastic chemicals ups asthma risk in male offspring

09 Mar 2023

Prenatal exposure to plastic-derived chemicals, such as bisphenol A (BPA) and phthalates, tends to increase the risk of asthma, particularly in males, a study has shown.

Prenatal exposure to plastic chemicals ups asthma risk in male offspring

09 Mar 2023

Sugar-sweetened beverage intake promotes weight gain in children, adults

06 Mar 2023

Consumption of sugar-sweetened beverages (SSBs) may lead to higher body mass index (BMI) and body weight in both children and adults, as shown in a systematic review and meta-analysis.

Sugar-sweetened beverage intake promotes weight gain in children, adults

06 Mar 2023

Original New Drug Application Approvals by US FDA (16-28 February 2023)

28 Feb 2023

New drug applications approved by US FDA as of 16-28 February 2023 which includes New Molecular Entities (NMEs) and new biologics. It does not include Tentative Approvals. Supplemental approvals may have occurred since the original approval date.

Original New Drug Application Approvals by US FDA (16-28 February 2023)

28 Feb 2023

Labetalol, nifedipine equally effective for chronic hypertension in pregnancy

23 Feb 2023 by

Treatment with either labetalol or nifedipine is similarly effective in reducing adverse maternal outcomes among women with mild chronic hypertension (CHTN) in pregnancy, according to a study presented at SMFM 2023.

Labetalol, nifedipine equally effective for chronic hypertension in pregnancy

23 Feb 2023

Atropine eye drops may lower incidence of myopia in kids

20 Feb 2023 by

Nightly use of 0.05% atropine eye drops among children appears to lead to a significantly lower incidence of near-sightedness, as shown in the results of the LAMP2 study from Hong Kong.

Atropine eye drops may lower incidence of myopia in kids

20 Feb 2023

Original-New-Drug-Application-Approvals-by-US-FDA--01-15-February-2023

20 Feb 2023

New drug applications approved by US FDA as of 01-15 February 2023 which includes New Molecular Entities (NMEs) and new biologics. It does not include Tentative Approvals. Supplemental approvals may have occurred since the original approval date.

Original-New-Drug-Application-Approvals-by-US-FDA--01-15-February-2023

20 Feb 2023

Childhood maltreatment linked to mental health problems

19 Feb 2023

A recent study has strengthened the view that childhood maltreatment contributes to mental health problems. In addition, findings suggest wider genetic and environmental risk factors mediate part of the overall mental health problem risk in those exposed to maltreatment.

Childhood maltreatment linked to mental health problems

19 Feb 2023

Rising cases of community-acquired E. coli UTI in children a cause for concern

18 Feb 2023

A recent study has found an increasing prevalence of community-acquired (CA) urinary tract infection (UTI) by emerging spectrum-β-lactamase-producing (ESBL) E. coli in children, with most isolates showing resistance to multiple drugs.

Rising cases of community-acquired E. coli UTI in children a cause for concern

18 Feb 2023

Standard dose vitamin D sufficient for bone mineral accretion in infants

17 Feb 2023

A higher dose does not provide added benefits than a standard dose when it comes to vitamin D supplementation for bone mineral accretion in infants born with vitamin D insufficiency, as reported in a recent study.

Standard dose vitamin D sufficient for bone mineral accretion in infants

17 Feb 2023

News & Updates

Filter by Specialty:

Specialty:

Pravastatin exposure during pregnancy carries no adverse neurodevelopmental risk for offspring

Pravastatin exposure during pregnancy carries no adverse neurodevelopmental risk for offspring

Prenatal exposure to plastic chemicals ups asthma risk in male offspring

Prenatal exposure to plastic chemicals ups asthma risk in male offspring

Sugar-sweetened beverage intake promotes weight gain in children, adults

Sugar-sweetened beverage intake promotes weight gain in children, adults

Original New Drug Application Approvals by US FDA (16-28 February 2023)

Original New Drug Application Approvals by US FDA (16-28 February 2023)

Labetalol, nifedipine equally effective for chronic hypertension in pregnancy

Labetalol, nifedipine equally effective for chronic hypertension in pregnancy

Atropine eye drops may lower incidence of myopia in kids

Atropine eye drops may lower incidence of myopia in kids

Original-New-Drug-Application-Approvals-by-US-FDA--01-15-February-2023

Original-New-Drug-Application-Approvals-by-US-FDA--01-15-February-2023

Childhood maltreatment linked to mental health problems

Childhood maltreatment linked to mental health problems

Rising cases of community-acquired E. coli UTI in children a cause for concern

Rising cases of community-acquired E. coli UTI in children a cause for concern

Standard dose vitamin D sufficient for bone mineral accretion in infants

Standard dose vitamin D sufficient for bone mineral accretion in infants